Patrick J. Nolan

Array ( [id] => 1304437 [patent_doc_number] => 06620914 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Transcription factor islet-brain 1 (IB1)' [patent_app_type] => B1 [patent_app_number] => 09/402214 [patent_app_country] => US [patent_app_date] => 1999-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 24 [patent_no_of_words] => 29041 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620914.pdf [firstpage_image] =>[orig_patent_app_number] => 09402214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1409996 [patent_doc_number] => 06521227 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-18 [patent_title] => 'Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides' [patent_app_type] => B1 [patent_app_number] => 09/461418 [patent_app_country] => US [patent_app_date] => 1999-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12516 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521227.pdf [firstpage_image] =>[orig_patent_app_number] => 09461418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 698836 [patent_doc_number] => RE039138 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2006-06-20 [patent_title] => 'Monoclonal antibody specific for advanced glycosylation endproducts in biological samples' [patent_app_type] => reissue [patent_app_number] => 09/465444 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11164 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039138.pdf [firstpage_image] =>[orig_patent_app_number] => 09465444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4257308 [patent_doc_number] => 06204058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Treatment of autoimmune diseases' [patent_app_type] => 1 [patent_app_number] => 9/465009 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6081 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204058.pdf [firstpage_image] =>[orig_patent_app_number] => 465009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416515 [patent_doc_number] => 06525187 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Polynucleotide encoding autoantigens associated with endometriosis' [patent_app_type] => B1 [patent_app_number] => 09/447399 [patent_app_country] => US [patent_app_date] => 1999-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 29745 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525187.pdf [firstpage_image] =>[orig_patent_app_number] => 09447399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4257096 [patent_doc_number] => 06258553 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Assay for measuring apoptosis in cell culture' [patent_app_type] => 1 [patent_app_number] => 9/444310 [patent_app_country] => US [patent_app_date] => 1999-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 12442 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258553.pdf [firstpage_image] =>[orig_patent_app_number] => 444310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6082995 [patent_doc_number] => 20020082393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'SECRETED SALIVARY ZSIG32 POLYPEPTIDES' [patent_app_type] => new [patent_app_number] => 09/442952 [patent_app_country] => US [patent_app_date] => 1999-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25716 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082393.pdf [firstpage_image] =>[orig_patent_app_number] => 09442952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493354 [patent_doc_number] => 06403089 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Methods of modulating immune coagulation' [patent_app_type] => B1 [patent_app_number] => 09/442143 [patent_app_country] => US [patent_app_date] => 1999-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 25335 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403089.pdf [firstpage_image] =>[orig_patent_app_number] => 09442143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1211781 [patent_doc_number] => 06709653 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-23 [patent_title] => 'Antibodies specific for human inositol monophosphatase H1' [patent_app_type] => B1 [patent_app_number] => 09/440113 [patent_app_country] => US [patent_app_date] => 1999-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13012 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/709/06709653.pdf [firstpage_image] =>[orig_patent_app_number] => 09440113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494098 [patent_doc_number] => 06342394 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Diagnosis of autoimmune adrenal disease' [patent_app_type] => B1 [patent_app_number] => 09/341391 [patent_app_country] => US [patent_app_date] => 1999-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4658 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342394.pdf [firstpage_image] =>[orig_patent_app_number] => 09341391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922913 [patent_doc_number] => 20020115599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'MICROTUBULE-ASSOCIATED TPX2 PROTEIN' [patent_app_type] => new [patent_app_number] => 09/431226 [patent_app_country] => US [patent_app_date] => 1999-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6802 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115599.pdf [firstpage_image] =>[orig_patent_app_number] => 09431226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093473 [patent_doc_number] => 06825325 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-30 [patent_title] => 'Molecular pathogenicide mediated plant disease resistance' [patent_app_type] => B1 [patent_app_number] => 09/419788 [patent_app_country] => US [patent_app_date] => 1999-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 53 [patent_no_of_words] => 46184 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825325.pdf [firstpage_image] =>[orig_patent_app_number] => 09419788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080457 [patent_doc_number] => 20020081625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY AND USES THEREOF' [patent_app_type] => new [patent_app_number] => 09/417791 [patent_app_country] => US [patent_app_date] => 1999-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 32633 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081625.pdf [firstpage_image] =>[orig_patent_app_number] => 09417791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1264022 [patent_doc_number] => 06660468 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'Vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction' [patent_app_type] => B1 [patent_app_number] => 09/413958 [patent_app_country] => US [patent_app_date] => 1999-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 7869 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660468.pdf [firstpage_image] =>[orig_patent_app_number] => 09413958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446342 [patent_doc_number] => 06368797 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant BPIIb allele' [patent_app_type] => B1 [patent_app_number] => 09/409648 [patent_app_country] => US [patent_app_date] => 1999-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12565 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368797.pdf [firstpage_image] =>[orig_patent_app_number] => 09409648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1325036 [patent_doc_number] => 06602853 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-05 [patent_title] => 'Antigenic peptides reacting with anti-ovary antibodies' [patent_app_type] => B1 [patent_app_number] => 09/331872 [patent_app_country] => US [patent_app_date] => 1999-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5194 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/602/06602853.pdf [firstpage_image] =>[orig_patent_app_number] => 09331872 [rel_patent_id] =>[rel_patent_doc_number] =>)